,42 Fluorescent staining revealed decreased MAP-2 intensity in the CA1 region of AD transgenic mice compared with WT littermates, which was restored following BDNF treatment (Fig. 3F, G), indicating enhanced neuronal structure. Here, MAP2 is linked to Alzheimer disease.